Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (>or=65 years of age): a phase II North Central Cancer Treatment Group study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples